Hysterectomy and OPPortunistic SAlpingectomy (HOPPSA)
Hysterectomy and Opportunistic Salpingectomy
Sponsor: Göteborg University
Listed as NCT03045965, this NA trial focuses on Complication and Ovarian Cancer and remains ongoing. Sponsored by Göteborg University, it has been updated 12 times since 2017, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
12 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2025 — Feb 2026 [monthly]
Recruiting NA
-
May 2025 — Sep 2025 [monthly]
Recruiting NA
-
Sep 2024 — May 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
▶ Show 7 earlier versions
-
May 2023 — Jul 2024 [monthly]
Recruiting NA
-
Apr 2022 — May 2023 [monthly]
Recruiting NA
-
Jan 2021 — Apr 2022 [monthly]
Recruiting NA
-
Dec 2018 — Jan 2021 [monthly]
Recruiting NA
-
Jun 2018 — Dec 2018 [monthly]
Recruiting NA
-
Sep 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2017 — Sep 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Göteborg University
- Umeå University
- Vastra Gotaland Region
For direct contact, visit the study record on ClinicalTrials.gov .